CollPlant GAAP net loss narrows to $2.73 million in Q2 2026; revenue falls 40% to $108,000 vs Q2 2025

By Public Technologies
  • CollPlant posted a GAAP net loss of USD 2.7 million for the second quarter ended June 30, 2026; GAAP basic loss per share was USD 1.89.
  • GAAP revenue fell 40% to USD 108,000 from a year earlier; the decline was primarily attributed to lower rhCollagen-based product sales.
  • GAAP gross loss widened to USD 456,000 from USD 7,000, while GAAP operating expenses fell 31% to USD 2.2 million.
  • Cash and cash equivalents were USD 2.6 million at June 30, 2026; cash used in operating activities was USD 5.4 million for the six months.
  • September 2026 acquisition of LightSolver marked entry into photonic computing; CEO Yehiel Tal cited up to 80,000× acceleration in HLRS research.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collplant Biotechnologies Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609301720PR_NEWS_USPR_____LN60606) on September 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.